SE9401108D0 - Ophthalmic composition I - Google Patents

Ophthalmic composition I

Info

Publication number
SE9401108D0
SE9401108D0 SE9401108A SE9401108A SE9401108D0 SE 9401108 D0 SE9401108 D0 SE 9401108D0 SE 9401108 A SE9401108 A SE 9401108A SE 9401108 A SE9401108 A SE 9401108A SE 9401108 D0 SE9401108 D0 SE 9401108D0
Authority
SE
Sweden
Prior art keywords
amount
pct
weight
composition
polymer
Prior art date
Application number
SE9401108A
Other languages
English (en)
Swedish (sv)
Inventor
Timo Reunamaeki
Kari Lehmussaari
Eija Vartiainen
Olli Oksala
Sakari Alaranta
Esko Pohjala
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Priority to SE9401108A priority Critical patent/SE9401108D0/xx
Publication of SE9401108D0 publication Critical patent/SE9401108D0/xx
Priority to EE9600120A priority patent/EE03661B1/xx
Priority to BR9507438A priority patent/BR9507438A/pt
Priority to AT95914362T priority patent/ATE202921T1/de
Priority to PL95316584A priority patent/PL179433B1/pl
Priority to ES95914362T priority patent/ES2161874T3/es
Priority to DK95914362T priority patent/DK0752847T3/da
Priority to HU9602691A priority patent/HU223071B1/hu
Priority to DE69521686T priority patent/DE69521686T2/de
Priority to CA002186734A priority patent/CA2186734A1/en
Priority to MX9603918A priority patent/MX9603918A/es
Priority to DE0752847T priority patent/DE752847T1/de
Priority to JP7525423A priority patent/JPH10503470A/ja
Priority to RU96119953A priority patent/RU2139016C1/ru
Priority to CZ19962865A priority patent/CZ290987B6/cs
Priority to SK1239-96A priority patent/SK280492B6/sk
Priority to PT95914362T priority patent/PT752847E/pt
Priority to RO96-01877A priority patent/RO115409B1/ro
Priority to PCT/FI1995/000166 priority patent/WO1995026711A1/en
Priority to CN95192185A priority patent/CN1112918C/zh
Priority to EP95914362A priority patent/EP0752847B1/en
Priority to US08/535,037 priority patent/US5710182A/en
Priority to KR1019960705391A priority patent/KR100365914B1/ko
Priority to AU21389/95A priority patent/AU694497B2/en
Priority to FI963744A priority patent/FI117921B/fi
Priority to NO19964070A priority patent/NO314434B1/no
Priority to BG100915A priority patent/BG63145B1/bg
Priority to HK98115146A priority patent/HK1013953A1/xx
Priority to GR20010401621T priority patent/GR3036763T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9401108A 1994-03-31 1994-03-31 Ophthalmic composition I SE9401108D0 (sv)

Priority Applications (29)

Application Number Priority Date Filing Date Title
SE9401108A SE9401108D0 (sv) 1994-03-31 1994-03-31 Ophthalmic composition I
AU21389/95A AU694497B2 (en) 1994-03-31 1995-03-29 Ophthalmic composition with decreased viscosity
JP7525423A JPH10503470A (ja) 1994-03-31 1995-03-29 減少した粘度を有する眼科治療用組成物
CZ19962865A CZ290987B6 (cs) 1994-03-31 1995-03-29 Oční přípravek se sníľenou viskozitou
AT95914362T ATE202921T1 (de) 1994-03-31 1995-03-29 Ophtalmische zubereitung niedriger viskosität
PL95316584A PL179433B1 (pl) 1994-03-31 1995-03-29 Kompozycja do oczu w postaci wodnego roztworu do miejscowego stosowania PL PL
ES95914362T ES2161874T3 (es) 1994-03-31 1995-03-29 Composicion oftalmica con viscosidad reducida.
DK95914362T DK0752847T3 (da) 1994-03-31 1995-03-29 Ophthalmisk sammensætning med nedsat viskositet
HU9602691A HU223071B1 (hu) 1994-03-31 1995-03-29 Csökkentett viszkozitású szemészeti készítmény
DE69521686T DE69521686T2 (de) 1994-03-31 1995-03-29 Ophtalmische zubereitung niedriger viskosität
CA002186734A CA2186734A1 (en) 1994-03-31 1995-03-29 Ophthalmic composition with decreased viscosity
MX9603918A MX9603918A (es) 1994-03-31 1995-03-29 Composicion oftalmica con viscosidad disminuida.
DE0752847T DE752847T1 (de) 1994-03-31 1995-03-29 Ophtalmische zubereitung niedriger viskosität
EE9600120A EE03661B1 (et) 1994-03-31 1995-03-29 Vähendatud viskoossusega oftalmoloogiline kompositsioon
RU96119953A RU2139016C1 (ru) 1994-03-31 1995-03-29 Офтальмическая композиция на основе водного раствора ионочувствительного гидрофильного полимера (варианты)
BR9507438A BR9507438A (pt) 1994-03-31 1995-03-29 Composição oftálmica com viscosidade reduzida
SK1239-96A SK280492B6 (sk) 1994-03-31 1995-03-29 Očný prípravok so zníženou viskozitou
PT95914362T PT752847E (pt) 1994-03-31 1995-03-29 Composicao oftalmica com viscosidade reduzida
RO96-01877A RO115409B1 (ro) 1994-03-31 1995-03-29 Compozitie oftalmica cu viscozitate scazuta
PCT/FI1995/000166 WO1995026711A1 (en) 1994-03-31 1995-03-29 Ophthalmic composition with decreased viscosity
CN95192185A CN1112918C (zh) 1994-03-31 1995-03-29 低粘度的眼药组合物
EP95914362A EP0752847B1 (en) 1994-03-31 1995-03-29 Ophthalmic composition with decreased viscosity
US08/535,037 US5710182A (en) 1994-03-31 1995-03-29 Ophthalmic composition
KR1019960705391A KR100365914B1 (ko) 1994-03-31 1995-03-29 점도가감소된안약조성물
FI963744A FI117921B (fi) 1994-03-31 1996-09-20 Alennetun viskositeetin omaava oftalminen koostumus
NO19964070A NO314434B1 (no) 1994-03-31 1996-09-27 Lav-viskositets oftalmisk blanding
BG100915A BG63145B1 (bg) 1994-03-31 1996-10-16 Офталмологичен състав с понижен вискозитет
HK98115146A HK1013953A1 (en) 1994-03-31 1998-12-23 Ophthalmic composition with decreased viscosity
GR20010401621T GR3036763T3 (en) 1994-03-31 2001-09-28 Ophthalmic composition with decreased viscosity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9401108A SE9401108D0 (sv) 1994-03-31 1994-03-31 Ophthalmic composition I

Publications (1)

Publication Number Publication Date
SE9401108D0 true SE9401108D0 (sv) 1994-03-31

Family

ID=20393511

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9401108A SE9401108D0 (sv) 1994-03-31 1994-03-31 Ophthalmic composition I

Country Status (27)

Country Link
US (1) US5710182A (zh)
EP (1) EP0752847B1 (zh)
JP (1) JPH10503470A (zh)
KR (1) KR100365914B1 (zh)
CN (1) CN1112918C (zh)
AT (1) ATE202921T1 (zh)
AU (1) AU694497B2 (zh)
BG (1) BG63145B1 (zh)
BR (1) BR9507438A (zh)
CA (1) CA2186734A1 (zh)
CZ (1) CZ290987B6 (zh)
DE (2) DE69521686T2 (zh)
DK (1) DK0752847T3 (zh)
EE (1) EE03661B1 (zh)
ES (1) ES2161874T3 (zh)
GR (1) GR3036763T3 (zh)
HK (1) HK1013953A1 (zh)
HU (1) HU223071B1 (zh)
MX (1) MX9603918A (zh)
NO (1) NO314434B1 (zh)
PL (1) PL179433B1 (zh)
PT (1) PT752847E (zh)
RO (1) RO115409B1 (zh)
RU (1) RU2139016C1 (zh)
SE (1) SE9401108D0 (zh)
SK (1) SK280492B6 (zh)
WO (1) WO1995026711A1 (zh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
WO2000064528A1 (en) 1999-04-28 2000-11-02 Situs Corporation Drug delivery system
US6852688B2 (en) 2000-03-10 2005-02-08 University Of Florida Compositions for treating diabetic retinopathy and methods of using same
MXPA04008171A (es) * 2002-02-22 2004-11-26 Pharmacia Corp Formulacion oftalmica con sistema de goma.
CA2476935C (en) * 2002-02-22 2013-05-28 Santen Pharmaceutical Co., Ltd. Drug delivery system for subconjunctival administration of fine particles
JP2004196787A (ja) * 2002-12-04 2004-07-15 Santen Pharmaceut Co Ltd 結膜下デポによるドラッグデリバリーシステム
WO2004050060A1 (ja) * 2002-12-04 2004-06-17 Santen Pharmaceutical Co., Ltd. 結膜下デポによるドラッグデリバリーシステム
CA2839930C (en) * 2003-06-13 2016-07-05 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
WO2005018608A1 (ja) * 2003-08-20 2005-03-03 Santen Pharmaceutical Co., Ltd. 微粒子テノン嚢下投与ドラッグデリバリーシステム
TWI367098B (en) * 2004-12-23 2012-07-01 Kowa Co Treating agent for glaucoma
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
DE102005035986B4 (de) * 2005-07-28 2009-10-15 Bausch & Lomb Incorporated Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat
EP2334686B1 (en) 2008-08-28 2019-02-27 President and Fellows of Harvard College Cortistatin analogues and syntheses therof
EP2383286A1 (en) 2010-04-30 2011-11-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treatment of retinal degenerative diseases
WO2012108489A1 (ja) * 2011-02-10 2012-08-16 参天製薬株式会社 親水性薬物の薬物移行性を改善した水性組成物
US20150038557A1 (en) 2012-02-24 2015-02-05 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and compositions for treatment of retinal degenerative diseases
CA2934819A1 (en) 2013-12-24 2015-07-02 President And Fellows Of Harvard College Cortistatin analogues and syntheses and uses thereof
EP3294298A4 (en) 2015-05-08 2018-10-17 President and Fellows of Harvard College Cortistatin analogues, syntheses, and uses thereof
WO2017004411A1 (en) 2015-07-01 2017-01-05 President And Fellows Of Harvard College Cortistatin analogues and syntheses and uses thereof
EP3340982B1 (en) 2015-08-26 2021-12-15 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
CN109475756A (zh) 2016-02-17 2019-03-15 儿童医疗中心有限公司 Ffa1(gpr40)作为神经血管生成疾病或病症的治疗标靶
AU2017290593A1 (en) 2016-06-27 2019-01-03 Achillion Pharmaceuticals, Inc. Quinazoline and indole compounds to treat medical disorders
WO2018033854A1 (en) * 2016-08-15 2018-02-22 Santen Pharmaceutical Co., Ltd. Ophthalmic composition and a method for treating ocular hypertension and glaucoma
CN116726006A (zh) 2016-08-19 2023-09-12 阿拉西斯医药公司 眼科药物组合物及其相关用途
HUE056595T2 (hu) * 2017-05-11 2022-02-28 Vyluma Inc Atropin gyógyászati kompozíciók
JP2021519337A (ja) 2018-03-26 2021-08-10 シー４ セラピューティクス， インコーポレイテッド Ｉｋａｒｏｓの分解のためのセレブロン結合剤
EP3841086A4 (en) 2018-08-20 2022-07-27 Achillion Pharmaceuticals, Inc. PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MEDICAL DISORDERS RELATED TO COMPLEMENT FACTOR D
EP3866773A4 (en) 2018-10-16 2022-10-26 Georgia State University Research Foundation, Inc. CARBON MONOXIDE PRODRUGS FOR THE TREATMENT OF MEDICAL CONDITIONS
CA3205883A1 (en) * 2021-02-04 2022-08-11 Gregory I. Ostrow Ophthalmic compositions for presbyopia
EP4088714A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
EP4088713A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
CN113786380A (zh) * 2021-09-18 2021-12-14 华北制药股份有限公司 一种硝酸毛果芸香碱眼用凝胶及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
FR2678832B1 (fr) * 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.

Also Published As

Publication number Publication date
SK123996A3 (en) 1997-06-04
BG63145B1 (bg) 2001-05-31
BR9507438A (pt) 1997-09-16
RO115409B1 (ro) 2000-02-28
PL179433B1 (pl) 2000-09-29
EP0752847B1 (en) 2001-07-11
EE9600120A (et) 1997-04-15
DE69521686D1 (de) 2001-08-16
BG100915A (en) 1997-07-31
NO964070D0 (no) 1996-09-27
NO964070L (no) 1996-11-28
ES2161874T3 (es) 2001-12-16
HUT75666A (en) 1997-05-28
CN1144477A (zh) 1997-03-05
HK1013953A1 (en) 1999-09-17
ATE202921T1 (de) 2001-07-15
HU223071B1 (hu) 2004-03-01
RU2139016C1 (ru) 1999-10-10
AU2138995A (en) 1995-10-23
WO1995026711A1 (en) 1995-10-12
JPH10503470A (ja) 1998-03-31
PT752847E (pt) 2001-12-28
AU694497B2 (en) 1998-07-23
US5710182A (en) 1998-01-20
NO314434B1 (no) 2003-03-24
CZ286596A3 (en) 1997-04-16
KR100365914B1 (ko) 2003-04-16
CN1112918C (zh) 2003-07-02
HU9602691D0 (en) 1996-11-28
KR970702024A (ko) 1997-05-13
CA2186734A1 (en) 1995-10-12
CZ290987B6 (cs) 2002-11-13
DE752847T1 (de) 1997-09-04
MX9603918A (es) 1997-04-30
GR3036763T3 (en) 2001-12-31
PL316584A1 (en) 1997-01-20
DK0752847T3 (da) 2001-10-22
EE03661B1 (et) 2002-04-15
SK280492B6 (sk) 2000-03-13
DE69521686T2 (de) 2002-04-25
EP0752847A1 (en) 1997-01-15

Similar Documents

Publication Publication Date Title
SE9401108D0 (sv) Ophthalmic composition I
SE9401109D0 (sv) Opthalmic composition II
US5945121A (en) Liposome eye drops
CA2183547A1 (en) Compositions for treating defective cell functions
DE60012068D1 (de) Zusammensetzung mit kontinuierlicher wässeriger Phase, die L-2-Oxothiazolidin- 4-carbonsäure enthält".
WO2009006130A3 (en) Salt free hyaluronate ophthalmic solution
DE3625867C2 (de) Verwendung von Tetrachlordecaoxid in der Ophthalmologie
JPS6452727A (en) Antiallergic eye drop
FI963744A (fi) Alennetun viskositeetin omaava oftalminen koostumus
AU2001242398A1 (en) Contact lens treating method and composition